// App-Quantinova.ai

Tu1427 : Interleukin-10 and TGF-1 Anti-Inflammatory Cytokine Gene Polymorphisms Are Involved in the Pathophysiology of Irritable Bowel Syndrome: a Meta-Analysis

Researchers

Presenter

  • Mohammad Bashashati

Principal Investigators

  • Nima Rezaei

  • Hossein Bashashati

  • Arezoo Shafieyoun

  • Nasser Ebrahimi Daryani

  • Keith A Sharkey

  • Martin Storr

Medical Centers

  • Ludwig Maximilians University Munich, Munich, Germany

  • Electrical and Computer Engineering Department, University of British Colombia, Vancouver, BC, Canada

  • Gastrointestinal Research Group, Snyder Institute of Infection, Immunity and Inflammation and Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada

Locations

  • Germany

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Irritable Bowel Syndrome

Biomarkers

  • Cytokine

  • Interleukin 10

  • Tumor necrosis factor

Drug/Treatment

  • Interleukin-10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved